News
Neuralink shouldn’t solve Anxiety and Depression disorders
Neuralink aims to treat some of the most severe and damaging neurological diseases on Earth. In terms of Alzheimer’s, dementia, and epilepsy, a Neuralink device would be a great way to prevent these diseases from ruining everyday life for those who have been affected by them. With that being said, Neuralink needs not to treat anxiety and depression disorders, because those illnesses require human reaction and vulnerability to treat. Defeating anxiety and depression should be done without the help of a complete fix, and it is crucial not to look past the importance of humans being able to feel these two sensations.
This is something I feel very strongly about for several reasons.
Before I dive into those reasons, I want to explain why I feel qualified enough to take a stance that I think many supporters of Neuralink will disagree with.
I have dealt with clinical anxiety and severe depression for my entire life. I was clinically diagnosed in 2009 at the age of 14 with both of these disorders, and I would estimate that it took me around 11 and a half years of diligence on my part to begin living a normal life. My anxiety and depression disorders hindered me from doing a lot of things in my life: playing certain sports, moving away for college (on multiple occasions), keeping past jobs, committing to relationships, etc. It has affected me in the worst way for so many years, and I would never want anyone, even my worst enemy, to experience the things that I felt on a daily basis when I was under the control of these two diseases.
However, I don’t think that everyone should completely rid themselves of anxiety and depression. Why? Because they are two emotions, as humans, we need to have.
Anxiety, while painful and difficult to confront head-on, is necessary for some reasons. The first being the obvious, anxiety is an excellent way to sense when danger is near, and it is a crucial part of our fight or flight response. It can warn someone when there is an issue with what is going on near them and can be life-saving in certain circumstances.
Anxiety also is an opportunity to grow as a human being. Facing and confronting anxious thoughts is one of the best ways to test resilience and learn about what we are made of. Anxiety teaches us a lot about ourselves, and while frightening, facing it directly is one of the best ways to show that we can push through certain circumstances that we aren’t confident about.
This is a preview from our weekly newsletter. Each week I go ‘Beyond the News’ and handcraft a special edition that includes my thoughts on the biggest stories, why it matters, and how it could impact the future.
A big thanks to our long-time supporters and new subscribers! Thank you.
Depression, while more severe in my own experiences, also has its advantages. Without darkness, we wouldn’t know what light is. Without depression, we wouldn’t know about happiness. There are points where humans need to face adversity and challenging circumstances to feel the great things about life.
Now, the way I treated my anxiety and depression disorders was a clinically-focused approach. I regularly attended therapy sessions, took medication, and spoke to doctors as often as I could. While I wholeheartedly believe everyone should talk to a therapist at least three times a year, I disagree with taking medications. In my experience, they are a masking agent for anxiety and depression disorders, especially. They caused me more problems after I started taking them, and the side effects needed treatment on their own.
I believe the best way to treat disorders like anxiety and depression is solely up to the person who is dealing with them. When I started to make real progress with my issues, I began using Exposure Therapy to treat my problems. I did as many things as I could that scared me. This included long drives by myself, roller coasters, and doing more things independently. When I started doing these things, I had stopped taking medication, and my self-diligence started to solve the problems I was facing.
I am in no way condoning that medication is not a wrong way to initially treat these illnesses. However, I do not believe that the healthy dose of side effects that come as a result of taking these medications is helpful to anyone who is being treated for either disorder.
This is where my issue with Neuralink comes in.
I believe that Neuralink intends to completely remove these sensations from a person’s emotions, which I feel can be dangerous to the future. Taking away emotions from humans can be detrimental to the way people communicate with each other and respond to specific events. As hazardous and as stressful as dealing with any mental illness is, solving them requires a long and tiring fight. It is not easy, but anything in life that is worth doing rarely is.
I believe very strongly that removing emotions from humans is one of the most dangerous things that anyone could do. At what point will devices like Neuralink completely take over the human brain? When will emotions begin to disappear from people? Could it lead to a decreased amount of social interaction? How would that make us any different than robots?
It is dangerous, in my opinion, to remove core emotional responses from a human. Nobody wants to be depressed, and nobody wants to be anxious. But treating these diseases is done by finding out who we are as people. It requires us to go out of our comfort zones and grow, not put a chip in our heads or a pill in our throats that eliminates the possibility of feeling certain sensations.
There comes the point where our humanness needs to be preserved. The invention of Smartphones has taken away a lot of opportunities for face-to-face interaction, and there is plenty of evidence to suggest that anxiety and depression disorders are caused by these devices, especially through social media use.
I am interested to hear other points on this matter because I know some people have different experiences with anxiety and depression than me. One thing I’ve always loved is hearing other people’s stories about how their anxiety or depression changed their lives. It usually starts with a valley and turns into a peak. While this can differ from case to case, two people rarely have identical stories when talking about their experiences. They also, frequently, are different from one case to the next because of how we obtained anxiety or depression. Some get it through abuse, and some get it from other forms of trauma when their brain is developing.
Neuralink is yet another brilliant idea from Elon Musk. It will hopefully change the way certain neurological diseases are treated and can provide some insight into what causes these medical conditions. However, there has to be boundaries and taking emotions and psychological responses away, in my opinion, is not the right thing to do. To quote Dr. Martin Luther King Jr., “Darkness cannot drive out darkness; only light can do that.”
I use this newsletter to share my thoughts on what is going on in the Tesla world. If you want to talk to me directly, you can email me or reach me on Twitter. I don’t bite, be sure to reach out!
Tesla CEO Elon Musk posted a photo of himself standing with the Optimus production team inside Tesla’s Fremont factory, arms crossed amid workers in hard hats and safety vests. The image captures a pivotal industrial shift: the same facility space once dedicated to building Tesla’s flagship Model S sedan and Model X SUV is now home to the company’s humanoid robot manufacturing line.
Walking the Optimus production line in Fremont pic.twitter.com/ABS0tuRibW
— Elon Musk (@elonmusk) July 1, 2026
Tesla’s Fremont Factory, acquired in 2010 from the former NUMMI joint venture between Toyota and GM, has been the company’s original U.S. manufacturing hub since Model S production began in 2012.
The Model X followed soon thereafter. These premium vehicles offered lower annual volumes, recently around 30,000 combined, compared to the high-volume Model 3 and Model Y lines that continue around the site. Over their combined run, the S and X accounted for roughly 610,000 units.
In late January 2026, during Tesla’s Q4 2025 earnings call, Elon Musk announced the end of Model S and Model X production in Q2 2026. The final vehicles rolled off the line in early May. Rather than retooling for another vehicle, Tesla chose to convert the dedicated S/X assembly area into a dedicated Optimus Gen 3 production line.
Model 3 and Y manufacturing remains unaffected. Tesla’s official Fremont Factory page now lists Optimus alongside the 3 and Y as core products.
The conversion was executed with remarkable speed. After production stopped, crews dismantled the existing vehicle line and installed entirely new modular equipment—including lines sourced from Germany and dozens of sub-lines for actuators, batteries, and other components—in roughly four months.
Musk described the timeline as “insanely fast,” noting it would be unprecedented for any other manufacturer. Initial Optimus output is expected to ramp slowly due to the robot’s roughly 10,000 unique parts and the brand-new production processes involved. The Fremont line targets an eventual capacity of 1 million Optimus units per year.
Tesla isn’t joking about building Optimus at an industrial scale: Here we go
Optimus Development Timeline
- August 19, 2021: Optimus (then called Tesla Bot) formally announced at Tesla’s first AI Day. A concept video showed a person in a suit demonstrating the vision for a general-purpose humanoid capable of dangerous, repetitive, or boring tasks using the same AI architecture as Full Self-Driving.
- 2022: Early prototypes displayed. At the second AI Day in September, semi-functional units demonstrated walking across a stage and basic arm movements
- 2023: September videos showed improved capabilities, including sorting colored blocks, precise limb awareness, and holding a Yoda pose.
- 2024-early 2025: Factory integration videos showed Optimus navigating workspaces and handling objects like battery cells.
- January 2026: Gen 3 mass-production activities began at Fremont, with reports of over 1,000 Gen 3 units already operating inside the factory for real-world learning and AI training
- April 2026: Musk confirms Optimus production on converted Fremont line would begin in late July or August 2026. The Gen 3 reveal, originally eyed for Q1, was pushed closer to production start. A second, much larger Optimus factory at Giga Texas is under construction, with volume production targeted for Summer 2027 and long-term capacity of 10 million units annually
- July 1, 2026: Musk’s on-site visit and team photo confirm the Optimus line is operational and the transition is actively progressing
Tesla positions Optimus as potentially its largest project ever, leveraging vertical integration, AI expertise, and car-like manufacturing know-how to scale humanoid robots first for its own factories and later for broader industrial and consumer use.
The Fremont conversion serves as a critical proving ground for this ambitious new chapter in Tesla’s already-rich history.
Investor's Corner
Tesla gets its latest short from Michael Burry: ‘Happy it jumped back to this level’
Tesla short seller Michael Burry, the subject of the film “The Big Short,” where he was portrayed by Steve Carell, has revealed he has opened a new bet against the stock.
In a new update to his Substack newsletter in a post titled “Trading Post June 30, 2026,” Burry revealed a new set of bets against Tesla, Caterpillar, NVIDIA, Applied Materials Inc., and the iShares Semiconductor ETF.
In regard to Tesla, Burry wrote:
“And finally I shorted Tesla at 416.22. Happy it jumped back to this level.”
This means Burry likely opened his new short position after the company’s recent rally on Wall Street, which saw Tesla shares sink in mid-May, only to recover to well over the $400 mark. Currently, shares trade at around $427.
The company saw a big Tuesday as shares climbed considerably, over 10 percent. The size of the Tesla short was not provided, nor did Burry give any information on the position’s structure, the number of shares, dollar value, or whether options were used in the short.
The Tesla and SpaceX merger everyone is talking about is quietly building
Over the years, Burry has been one of the more vocal critics of Tesla, calling its share price “media inflated,” and saying it was “ridiculously overvalued” as recently as December.
The company has largely transitioned away from being known as an automotive company and instead is much more widely regarded as an AI play, mostly due to its Full Self-Driving efforts, Optimus robot development, and data collection related to both.
This has not pulled those skeptics away from being vocal about their distaste for how Tesla is valued, but there’s no denying that the company is a global force in many things, including sustainable energy, automotive, and AI.
Wedbush Securities is initiating stock coverage on SpaceX (NASDAQ: SPCX), marking the first comments on the company since it went public several weeks ago. Wedbush and its analyst handling coverage, Dan Ives, are widely bullish on fellow Musk company Tesla (NASDAQ: TSLA).
Ives wrote his first note initiating coverage of SpaceX shares on Wednesday with a $190 price target and an ‘Outperform’ rating. The firm believes the company is well positioned off of its IPO because of its wide array of projects, including AI compute power and infrastructure, connectivity projects, and launches.
“We view SpaceX as one of the most differentiated assets within the tech market with a strong footprint across its three core markets, with Starlink driving success with connectivity,” Ives wrote, “Starship launches leading to a demand flywheel and increasing deal flow for its Colossus clusters.”
Elon Musk called it Epic: The full story of SpaceX’s Starship Flight 12
Wedbush leans heavily on Starlink, which they say is the “profitability driver given the strength of its recurring revenue base of ~12 million subscribers as of June 5th.” Ives believes Starlink is still in the “early innings” of penetrating the global telecommunications and broadband market, as it only holds less than a 1 percent share. However, this number is sure to increase over time.
It also highlights the importance of Starship, which it says is an “essential layer” of SpaceX’s overall success. SpaceX developing and displaying the ability to reuse rockets is a major cost and reliability advantage “as it reduces the necessary hardware launch costs while generating a feedback loop for future flights to improve their launch flight rate without accelerating capex spend.”
Finally, SpaceX’s recent AI/Compute projects are also very elementary, Ives writes. It is worth mentioning Wedbush said its $190 price target is derived from a valuation forecast that sees the company yielding roughly $2.48 trillion of implied enterprise value.
There are also some factors that Wedbush did not take into account with its initial coverage. The firm wrote in the note:
“We note that there is optional value coming from Starship’s accelerating scale towards sub-$200/kg unit economics, orbital data centers, and enterprise AI monetization as these factors could drive meaningful upside but these face major hurdles, so we do not take that into account with our valuation.”
SpaceX shares are down just over 2 percent today, trading at around $167 at the time of publication.
Tesla Optimus project fires up as Musk sees production line progress
Tesla gets its latest short from Michael Burry: ‘Happy it jumped back to this level’
